Scientific Letter
Rituximab therapy for refractory thrombocytopenia in patients with antiphospholipid antibodies
Uso de rituximab para trombocitopenia refractaria en pacientes con anticuerpos antifosfolípidos
Felisa Vázquez Gómeza,
, María Prieto Arcea, Luis Ignacio González-Granadob, Eugenia Enríquez Merayoc, Jaime de Inocencio Arocenac
a Unidad de Hemato-Oncología Pediátrica, Hospital Universitario 12 de Octubre, Madrid, Spain
b Unidad de Inmunodeficiencias, Pediatría, Hospital Universitario 12 Octubre, Instituto de Investigación, Hospital Universitario 12 de Octubre (i+12), Madrid, Spain
c Unidad de Reumatología Pediátrica, Hospital Universitario 12 de Octubre, Madrid, Spain
Leído
6333
Vecesse ha leído el artículo
2513
Total PDF
3820
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 7 | 66 | 29 | 95 |
| 2025 6 | 78 | 77 | 155 |
| 2025 5 | 87 | 32 | 119 |
| 2025 4 | 106 | 31 | 137 |
| 2025 3 | 82 | 21 | 103 |
| 2025 2 | 68 | 18 | 86 |
| 2025 1 | 52 | 17 | 69 |
| 2024 12 | 50 | 26 | 76 |
| 2024 11 | 62 | 48 | 110 |
| 2024 10 | 46 | 32 | 78 |
| 2024 9 | 46 | 33 | 79 |
| 2024 8 | 58 | 55 | 113 |
| 2024 7 | 59 | 28 | 87 |
| 2024 6 | 69 | 26 | 95 |
| 2024 5 | 48 | 43 | 91 |
| 2024 4 | 60 | 26 | 86 |
| 2024 3 | 51 | 21 | 72 |
| 2024 2 | 51 | 36 | 87 |
| 2024 1 | 51 | 23 | 74 |
| 2023 12 | 26 | 18 | 44 |
| 2023 11 | 32 | 25 | 57 |
| 2023 10 | 32 | 29 | 61 |
| 2023 9 | 41 | 20 | 61 |
| 2023 8 | 36 | 23 | 59 |
| 2023 7 | 37 | 28 | 65 |
| 2023 6 | 37 | 19 | 56 |
| 2023 5 | 47 | 13 | 60 |
| 2023 4 | 37 | 15 | 52 |
| 2023 3 | 88 | 19 | 107 |
| 2023 2 | 43 | 23 | 66 |
| 2022 1 | 32 | 31 | 63 |
| 2022 12 | 48 | 25 | 73 |
| 2022 11 | 46 | 34 | 80 |
| 2022 10 | 55 | 47 | 102 |
| 2022 9 | 42 | 33 | 75 |
| 2022 8 | 42 | 66 | 108 |
| 2022 7 | 29 | 53 | 82 |
| 2022 6 | 28 | 61 | 89 |
| 2022 5 | 37 | 49 | 86 |
| 2022 4 | 39 | 39 | 78 |
| 2022 3 | 39 | 49 | 88 |
| 2022 2 | 31 | 28 | 59 |
| 2021 1 | 51 | 45 | 96 |
| 2021 12 | 31 | 37 | 68 |
| 2021 11 | 40 | 47 | 87 |
| 2021 10 | 56 | 75 | 131 |
| 2021 9 | 36 | 47 | 83 |
| 2021 8 | 27 | 44 | 71 |
| 2021 7 | 32 | 43 | 75 |
| 2021 6 | 40 | 28 | 68 |
| 2021 5 | 42 | 94 | 136 |
| 2021 4 | 121 | 77 | 198 |
| 2021 3 | 68 | 31 | 99 |
| 2021 2 | 53 | 21 | 74 |
| 2020 1 | 32 | 15 | 47 |
| 2020 12 | 29 | 14 | 43 |
| 2020 11 | 38 | 26 | 64 |
| 2020 10 | 33 | 25 | 58 |
| 2020 9 | 31 | 13 | 44 |
| 2020 8 | 21 | 11 | 32 |
| 2020 7 | 26 | 25 | 51 |
| 2020 6 | 24 | 7 | 31 |
| 2020 5 | 23 | 21 | 44 |
| 2020 4 | 22 | 17 | 39 |
| 2020 3 | 33 | 12 | 45 |
| 2020 2 | 33 | 12 | 45 |
| 2020 1 | 37 | 21 | 58 |
| 2019 12 | 50 | 8 | 58 |
| 2019 11 | 32 | 15 | 47 |
| 2019 10 | 38 | 14 | 52 |
| 2019 9 | 16 | 12 | 28 |
| 2019 8 | 42 | 18 | 60 |
| 2019 7 | 33 | 17 | 50 |
| 2019 6 | 25 | 13 | 38 |
| 2019 5 | 30 | 32 | 62 |
| 2019 4 | 43 | 27 | 70 |
| 2019 3 | 30 | 15 | 45 |
| 2019 2 | 25 | 8 | 33 |
| 2019 1 | 15 | 22 | 37 |
| 2018 12 | 30 | 19 | 49 |
| 2018 11 | 51 | 23 | 74 |
| 2018 10 | 65 | 24 | 89 |
| 2018 9 | 30 | 33 | 63 |
| 2018 8 | 8 | 0 | 8 |
| 2018 7 | 4 | 0 | 4 |
| 2018 6 | 2 | 0 | 2 |
| 2018 5 | 3 | 0 | 3 |
| 2018 4 | 18 | 0 | 18 |
| 2018 3 | 17 | 0 | 17 |
| 2018 2 | 4 | 0 | 4 |
| 2018 1 | 26 | 0 | 26 |
| 2017 12 | 23 | 0 | 23 |
| 2017 11 | 14 | 0 | 14 |
| 2017 10 | 9 | 0 | 9 |
| 2017 9 | 20 | 0 | 20 |
| 2017 8 | 13 | 0 | 13 |
| 2017 7 | 3 | 3 | 6 |
| 2017 6 | 8 | 27 | 35 |
| 2017 5 | 0 | 6 | 6 |
Mostrar todo
